High hopes for cannabinoid agonists in the treatment of rheumatic diseases

There are two well-characterised isoforms of cannabinoid receptor; CB(1) and CB(2) and of these CB(2) is under active investigation as a potential target for treatment of the chronic pain associated with widespread and intractable joint diseases osteoarthritis and rheumatoid arthritis. The recent re...

Descripción completa

Detalles Bibliográficos
Autores principales: Staunton, Caroline A, Mobasheri, Ali, Barrett-Jolley, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289380/
https://www.ncbi.nlm.nih.gov/pubmed/25477254
http://dx.doi.org/10.1186/1471-2474-15-410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4289380/
https://www.ncbi.nlm.nih.gov/pubmed/25477254
http://dx.doi.org/10.1186/1471-2474-15-410

Ejemplares similares